Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Zaudig

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Clinical Psychopharmacology|May 18, 2010
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential studyParaskevi Mavorgiorgou, Doris Gohle, Christine Winter, et al.
Biological Psychiatry|December 17, 2003
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorderOliver Pogarell, Christine Hamann, Gabriele Pöpperl, et al.
Journal of Psychiatric Research|October 1, 2013
P300 in obsessive-compulsive disorder: source localization and the effects of treatmentChristina Andreou, Gregor Leicht, Vlad Popescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2004
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorderOliver Pogarell, Klaus Tatsch, Georg Juckel, et al.
Plos One|August 27, 2013
Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reportsGünter Schiepek, Igor Tominschek, Stephan Heinzel, et al.
Psychotherapy and Psychosomatics|September 13, 2020
Oxytocin Receptor Gene DNA Methylation: A Biomarker of Treatment Response in Obsessive-Compulsive Disorder?Miriam A Schiele, Christiane Thiel, Leonie Kollert, et al.
Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Clinical Psychopharmacology|May 18, 2010
Low serotonergic function and its normalization by treatment with sertraline in obsessive-compulsive disorder--an auditory evoked potential studyParaskevi Mavorgiorgou, Doris Gohle, Christine Winter, et al.
Biological Psychiatry|December 17, 2003
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorderOliver Pogarell, Christine Hamann, Gabriele Pöpperl, et al.
Journal of Psychiatric Research|October 1, 2013
P300 in obsessive-compulsive disorder: source localization and the effects of treatmentChristina Andreou, Gregor Leicht, Vlad Popescu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2004
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorderOliver Pogarell, Klaus Tatsch, Georg Juckel, et al.
Plos One|August 27, 2013
Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reportsGünter Schiepek, Igor Tominschek, Stephan Heinzel, et al.
Psychotherapy and Psychosomatics|September 13, 2020
Oxytocin Receptor Gene DNA Methylation: A Biomarker of Treatment Response in Obsessive-Compulsive Disorder?Miriam A Schiele, Christiane Thiel, Leonie Kollert, et al.
Lancet (London, England)|April 25, 2006
Mild cognitive impairmentSerge Gauthier, Barry Reisberg, Michael Zaudig, et al.
Pageof 4